Infectious Disease Diagnostics – Products

Screening tests are intended to identify infected individuals who may be contagious, regardless of whether they are displaying symptoms, so that measures can be taken to prevent those individuals from infecting others.

Porvair Sciences has further expanded its range of high-performance microplate products for SARS-CoV-2 nucleic acid purification.

The Native Antigen Company, part of LGC Clinical Diagnostics and a supplier of reagents that enables research into diagnostics and vaccines for emerging and endemic infectious diseases, won ‘The Best COVID-19 Responder’ at OBN 2020 Awards.

Avacta Group plc is pleased to announce that the MHRA has confirmed registration of Avacta’s AffiDX® SARS-CoV-2 antigen lateral flow test allowing the Company to place the product on the market in the UK for professional use.

Scientific Products has announced one of the world’s largest simultaneous installations of commercial lyophilizers for use in the production of diagnostic tests. The order, for SP lyophilizers, was made last year in response to the need for an increase in SARS-CoV-2 testing.

Oxford Immunotec has announced that its T-SPOT® Discovery SARS-CoV-2 kit is being used for T cell testing in the UK COVID-19 Human Challenge Study, a national collaboration including the UK government, the NHS, academia and the private sector.

Oxford Immunotec has announced that its T-SPOT®.COVID test will be used for T cell testing in the COV-AD (COVID infection in patients with Antibody Deficiency) study in collaboration with the University of Birmingham.

Bio-Rad Laboratories, Inc. has announced the launch of the Reliance SARS-CoV-2 RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements.

Oxford Immunotec has announced that its T-SPOT® Discovery SARS-CoV-2 kit will be used for T cell testing in the UK Com-COV trial.

Avacta Group plc has announced positive data from the clinical validation of its AffiDX® SARS-CoV-2 antigen lateral flow test.